ImmunityBio (IBRX) Shares Issued (2016 - 2024)
Historic Shares Issued for ImmunityBio (IBRX) over the last 11 years, with Q3 2024 value amounting to $15.6 million.
- ImmunityBio's Shares Issued changed N/A to $15.6 million in Q3 2024 from the same period last year, while for Jun 2025 it was $15.6 million, marking a year-over-year decrease of 7664.92%. This contributed to the annual value of $73.3 million for FY2024, which is N/A changed from last year.
- Per ImmunityBio's latest filing, its Shares Issued stood at $15.6 million for Q3 2024.
- In the past 5 years, ImmunityBio's Shares Issued ranged from a high of $93.9 million in Q2 2021 and a low of -$131.5 million during Q4 2021
- In the last 5 years, ImmunityBio's Shares Issued had a median value of $600000.0 in 2020 and averaged $6.8 million.
- As far as peak fluctuations go, ImmunityBio's Shares Issued tumbled by 9339.88% in 2022, and later skyrocketed by 4197619.05% in 2024.
- ImmunityBio's Shares Issued (Quarter) stood at $400000.0 in 2020, then plummeted by 32971.75% to -$131.5 million in 2021, then surged by 99.94% to -$74000.0 in 2022, then tumbled by 70.27% to -$126000.0 in 2023, then surged by 12494.44% to $15.6 million in 2024.
- Its last three reported values are $15.6 million in Q3 2024, $52.8 million for Q2 2024, and $14.1 million during Q1 2024.